Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension

被引：6
|
作者：
Fernandes, Caio J. C. S. [1 ,2 ,3 ]
da Silva, Taysa A. F. [1 ]
Alves Jr, Jose L. [1 ,2 ,3 ]
Jardim, Carlos V. P. [1 ,3 ]
de Souza, Rogerio [1 ,3 ]
机构：
[1] Univ Sao Paulo, Heart Inst, Med Sch, Pulm Circulat Unity,Cardiopulmonol Dept, 44 Dr Eneas Carvalho Aguiar Av, BR-05403000 Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Med Sch, Canc Inst, Sao Paulo, Brazil
[3] Sirio Libanes Hosp, Sao Paulo, Brazil
来源：
PULMONARY CIRCULATION | 2021年 / 11卷 / 01期
关键词：
inhaled iloprost; sequential triple combination therapy; pulmonary arterial hypertension; hemodynamics; COMBINATION THERAPY; REGISTRY;
D O I：
10.1177/2045894020981350
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and hemodynamical benefits of inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Inhaled iloprost as an add-on therapy for advanced pulmonary arterial hypertension: An Indian perspective
    Bobhate, Prashant
    Gupta, Rajat Kumar
    Karande, Tanuja
    Kulkarni, Snehal
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2022, 35 (06): : 338 - 343
  • [2] Inhaled iloprost for therapy in pulmonary arterial hypertension
    Ewert, Ralf
    Glaeser, Sven
    Bollmann, Tom
    Schaeper, Christoph
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (02) : 145 - 152
  • [3] Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension
    Channick, Richard N.
    Olschewski, Horst
    Seeger, Werner
    Staub, Ted
    Voswinckel, Robert
    Rubin, Lewis J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (07) : 1433 - 1437
  • [4] Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension
    Channick, RN
    Olschewski, H
    Seeger, W
    Staub, T
    Rubin, LJ
    [J]. CIRCULATION, 2005, 112 (17) : U566 - U566
  • [5] Inhaled iloprost in pulmonary arterial hypertension
    Baker, SE
    Hockman, RH
    [J]. ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1265 - 1274
  • [6] Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
    Hoeper, M. M.
    Leuchte, H.
    Halank, M.
    Wilkens, H.
    Meyer, F. J.
    Seyfarth, H. J.
    Wensel, R.
    Ripken, F.
    Bremer, H.
    Kluge, S.
    Hoeffken, G.
    Behr, J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (04) : 691 - 694
  • [7] Idiopathic pulmonary arterial hypertension and inhaled iloprost: Good night rebound effects?
    Domenighetti, Guido M.
    [J]. RESPIRATION, 2007, 74 (05) : 496 - 497
  • [8] Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension
    Olsson, Karen M.
    Richter, Manuel J.
    Kamp, Jan C.
    Gall, Henning
    Heine, Alexander
    Ghofrani, Hossein-Ardeshir
    Fuge, Jan
    Ewert, Ralf
    Hoeper, Marius M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (07): : 748 - 756
  • [9] Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension
    Ewert, R.
    Opitz, C. F.
    Wensel, R.
    Winkler, J.
    Halank, M.
    Felix, S. B.
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (04) : 211 - 217
  • [10] Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension
    Onen, Zeynep Pinar
    Yildiz, Onur Akkoca
    Gulbay, Banu Eris
    Karabiyikoglu, Gulseren
    [J]. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2006, 54 (02): : 177 - 181
12345